Bid document



SUBJECT*

Request for Information (RFI) - Specialty Pharmacy – Pharmaceutical Prime Vendor (PPV) 2028

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*

60141

SOLICITATION NUMBER*

36E79727Q0001

RESPONSE DATE/TIME/ZONE

11-16-2026 11AM CENTRAL TIME, CHICAGO, USA

ARCHIVE

60 DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

N

SET-ASIDE

PRODUCT SERVICE CODE*

6505

NAICS CODE*

325412

CONTRACTING OFFICE ADDRESS

Department of Veterans Affairs - OALC
Enterprise Procurement Office (EPO)
Acquisition Service 7 (AS7)
Bldg 37, PO Box 76

POINT OF CONTACT*

Chief, Pharmaceutical Division
Karen Ade
[email protected]
708-786-5231

PLACE OF PERFORMANCE

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

Department of Veterans Affairs, OALC, EPO AS7Request for Information (RFI)Specialty Pharmacy – Pharmaceutical Prime Vendor (PPV) 2028

Limited Distribution/Closed Distribution Products (CDP) are specialty medications that are generally high-cost, low-volume items for which manufacturers restrict distribution to a small, select network of authorized distributors outside traditional wholesale channels. Specialty Pharmacy dispensed prescriptions, must have a clinical justification or regulatory requirement to restrict dispensing to specialty pharmacies. These products may require additional pharmacy-performed activities such as product-specific registration, safety checks, monitoring, or compliance with manufacturer-mandated dispensing requirements. CDPs may or may not require pass-through delivery depending on the manufacturer's distribution model.

The contractor shall ensure that all Federal Supply Schedule (FSS) items requiring specialty distribution—including all those not currently/historically included or physically distributed through the Prime Vendor (PPV)—are orderable by authorized ordering officers through the pharmaceutical prime vendor ordering platform. When a product requires specialty distribution, the pharmaceutical distributor shall coordinate fulfillment directly with the manufacturer-designated specialty distributor, even in cases where physical possession or shipment bypasses the pharmaceutical prime vendor. The goal is to provide seamless ordering access, accurate invoicing, and visibility into CDP transactions while maintaining compliance with manufacturer restrictions and ensuring timely, compliant delivery to VA facilities. Market Research Questions:

Could this be included in the PPV scope? What is the potential impact on pricing, performance, and competition of bringing all FSS CDPs under PPV?